FL score
out of 100
Verdict
high confidence
Competition
No competitor data yet
Trend
No signal yet
Users of Dexscreener want a more affordable, updated platform with better features for crypto analytics and advertising.
The pain
The gap
Build angle
Strengths
- Clear user dissatisfaction with current pricing and product stagnation
- Large market of DeFi users and advertisers seeking better tools
- Opportunity to differentiate on pricing and innovation
Risks
- High competition from established players with strong network effects
- Technical complexity in building reliable, real-time DeFi analytics
- Uncertainty if users will switch platforms despite pricing improvements
Fly Labs Method
Is the pain real, is there a gap, is it the right time, can one person build it.
Value Equation
Dream outcome and how likely it feels, against the time and effort it costs.
One-Person Business
Curiosity pull, identity fit, and a path from free value to paid for a solo creator.
Viral Frameworks
Hook strength, shareability, and how cheaply it can be tested.
Builder Lens
Evidence the problem exists, timing, defensibility, and a model that fits on a napkin.
Five lenses, one composite. How scoring works
The angle
No market research recorded for this idea yet.
Small businesses need automated accounting but existing solutions are too complex or expensive
Small businesses, especially in emerging markets, struggle with manual bookkeeping and can't afford complex accounting software or professional services.
Finance
Disability benefit recipients need clarity on vehicle allowance rule changes
PIP recipients face new £400 charges due to Motability mileage allowance changes. Many don't understand the impact or have time to research. A tool could aggregate rule changes, calculate personal impact, and guide users through options. [Trending: "motability mileage allowance" with 500+ searches in GB]
Finance
Traders lack real-time average weighted funding rate tracker for Hyperliquid positions
HyperliquidX traders struggle to calculate and track average weighted funding rates for their long and short positions in real-time, leading to inaccurate risk assessment and unexpected costs as no dedicated tool exists.
Finance
Questions about this idea?
FlyBot reads the scoring and gives you a second opinion on “Outdated Dexscreener platform with high fees for basic features”.